Intuitive Surgical
Prix: 411.06Entreprise et modèle économique
Intuitive Surgical is a leader in robotic-assisted surgical systems, primarily known for its da Vinci Surgical System. The company develops and markets advanced surgical technologies, including instruments and accessories that enhance minimally invasive surgery. Its core revenue sources stem from system sales, instrument and accessory sales, and service agreements. The company operates mainly in the healthcare sector, focusing on improving surgical outcomes and patient recovery times.
Profil d’investissement
Intuitive Surgical's stock is more aligned with growth investors due to its focus on innovation and expanding market presence in robotic surgery. The absence of dividends and the current volatility suggest a higher risk profile, making it less suitable for conservative investors. The company is positioned for potential long-term growth, appealing to those willing to accept higher risk for future returns.
Métriques fondamentales (expérimental)
- BPA (TTM) — bénéfice par action des 12 derniers mois, $
- 8.37 OK
- Chiffre d’affaires QoQ — croissance trimestrielle du chiffre d’affaires
- -3.3% ↓
- Surprise BPA
- 17.9% meilleur que prévu
- Volatilité 20 j
- 2.5% stable
Impact de la prévision
négatifSuivre dans le portefeuille
Graphique des prix
| Date | Avant | Après | Raison |
|---|---|---|---|
| 2026-05-24 02:42 | Conserver | Vendre | Weak momentum and fundamentals suggest caution. |
| 2026-05-16 02:32 | Vendre | Conserver | Weak fundamentals and negative momentum raise significant concerns. |
| 2026-05-08 14:59 | — | Vendre | Weak momentum and fundamentals raise significant risk concerns. |
| Date | Analyste | Action | Objectif | Prix alors |
|---|---|---|---|---|
| 2026-06-02 12:24 | Piper Sandler | Mettre à jour | — → 580 | 397.60999 |
| 2026-05-27 11:27 | Goldman Sachs | Objectif abaissé | 621 → 558 | 436.64 |
| 2026-04-23 10:18 | Barclays | Objectif abaissé | 712 → 651 | 483.62 |
Rien pour le moment